DAVID GIGLIOTTI: Open Payments
NPI 1518920552 · BERLIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 10 payments from 4 companies in 2025. Trend: 2023 $8,084 · 2024 $5,729 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $179 |
| Lundbeck LLC | 3 | $142 |
| Braeburn Inc. | 1 | $122 |
| Novo Nordisk Inc | 2 | $29 |
Products named: VIVITROL, VYEPTI, BRIXADI, Wegovy, REXULTI.
Industry payments across NJ — which companies pay providers there.
